FDA Inspection 1232814 — Tarsal Pharmaceuticals, Inc.
The FDA completed an inspection of Tarsal Pharmaceuticals, Inc. on Jan 29, 2024 in Oceanside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 29, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Oceanside, CA (United States)